Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer
Clinical trial NCT01895491 · COMPLETED
Trial details
- NCT number
- NCT01895491
- Sponsor
- Reyon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.